For the three months ending 06/30/2025, net revenue from continuing operations was $10,800,000 which represented a 10% increase over the prior year period. Revenue for the first six months of the year totaled $22,600,000 a 23% increase over the 2024. Net revenue by product for the 2025 included $2,800,000 for Crystallis, 3,100,000.0 for SANKUSO, dollars 2,700,000.0 for Vibativ and $1,600,000 for Caldolor. Year to date product revenue totaled $6,200,000 for Cristalose, 4,100,000.0 for Vibativ, 5,400,000.0 for Sancuso and $2,900,000 for Caldolor. Turning to our expenditures, total operating expense for the second quarter were $11,600,000 Year to date expenses totaled 22,000,000 The net loss for the quarter was $700,000 a significant improvement over the prior year period.